DUOX1

Dual oxidase 1 · Q9NRD9 · DUOX1 on Sugi Atlas →

19 patent compounds predicted against DUOX1, 17 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL2027831 SCHEMBL2027831 1.00 1/20
SCHEMBL29368383 SCHEMBL29368383 1.00 1/20
SCHEMBL4923550 SCHEMBL4923550 0.80 1/20
SCHEMBL4920436 SCHEMBL4920436 0.78 1/20
SCHEMBL4928536 SCHEMBL4928536 0.73 1/20
SCHEMBL4920666 SCHEMBL4920666 0.71 1/20
SCHEMBL15313075 SCHEMBL15313075 0.69 1/20
SCHEMBL4920220 SCHEMBL4920220 0.69 1/20
SCHEMBL4928611 SCHEMBL4928611 0.68 1/20
SCHEMBL17210872 SCHEMBL17210872 0.67 1/20
SCHEMBL4937076 SCHEMBL4937076 0.66 1/20
SCHEMBL29490371 SCHEMBL29490371 0.66 1/20
SCHEMBL16560732 SCHEMBL16560732 0.63 1/20
SCHEMBL4941814 SCHEMBL4941814 0.60 1/20
SCHEMBL4918509 SCHEMBL4918509 0.57 1/20
SCHEMBL4930461 SCHEMBL4930461 0.57 1/20
SCHEMBL23585073 SCHEMBL23585073 0.47 1/20

Clinical trials — most relevant to DUOX1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
COMS for Chronic Ulcers Treatment PHASE4RECRUITING
Randomized Controlled Trial of Silymarin in Asthma PHASE2/PHASE3WITHDRAWN
Role of Vitamin E in Gaucher Disease Patients PHASE3COMPLETED
Endothelial Dysfunction and Oxidative Stress in Children With Sleep Disordered Breathing. PHASE1/PHASE2COMPLETED
Effects of Febuxostat for Lowering Uric Acid in NAFLD Patients With Gout PHASE2UNKNOWN
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers PHASE2NOT_YET_RECRUITING
NOX-100 for Preventing Hypotension During Hemodialysis PHASE2COMPLETED
Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes PHASE2UNKNOWN
Possible Effects of Propylthiouracil, Riociguat and Perphenazine on Circulation of Healthy Volunteers PHASE1COMPLETED
Endometriosis and Microvascular Dysfunction: Role of Inflammation EARLY_PHASE1RECRUITING
Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease EARLY_PHASE1RECRUITING
GSNOR Phenotyping/GSNO Challenge in Severe Asthma EARLY_PHASE1COMPLETED
Prognostic Value of (DHODH) Expression in (HGSOC): A Comparative Study Between Neoadjuvant and Adjuvant Chemotherapy Settings nanNOT_YET_RECRUITING
Mechanisms of Action of Acetaminophen nanCOMPLETED
Sex-specific Association With Kidney Disease nanCOMPLETED
Covid-19: Possible Role of Neutrophil Extracellular Traps nanUNKNOWN
Prevalence of DAO (diamino Oxidase) Deficiency in Newborns nanCOMPLETED
NCF Gene & TNFSF4 in SLE Patients nanUNKNOWN
Role of A Disintegrin and Metalloproteinase (ADAM) in Epithelial Dysfunction nanCOMPLETED
Immunological Profile and Clinical Characteristics of Children Diagnosed With Chronic Granulomatous Disease nanUNKNOWN
Reactive Oxygen Species Following Aortic Valve Replacement nanCOMPLETED
Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19 nanCOMPLETED
Role of Nox2 in CNI-induced Renal Fibrosis nanCOMPLETED
A Feasibility Study: Assessing Photobiomodulation in Myalgic Encephalomyelitis nanUNKNOWN
Neutrophil Oxidative Burst in Early and Late Onset Pediatric Inflammatory Bowel Disease nanUNKNOWN
Lung Mucus Hypersecretion and NQO1 nanCOMPLETED
Replacement of Vitamin D in Patients With Active Tuberculosis nanCOMPLETED
Redox Determinants of Severe Asthma (a Substudy of the Severe Asthma Research Program) nanCOMPLETED
Markers of Inflammation and Lung Recovery in ECMO Patients for PPHN nanCOMPLETED
Chronic Obstructive Pulmonary Disease Gene Localization nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a DUOX1 binder may also engage these)

ProteinNameSimilarity
Q8HZK3 1.000 Q8HZK3 →
DUOX2 Dual oxidase 2 1.000 landscape →
Q8HZK2 1.000 Q8HZK2 →
Q9MZF4 1.000 Q9MZF4 →
A2AQ92 1.000 A2AQ92 →
Q8CIY2 0.998 Q8CIY2 →
Q9ES45 0.998 Q9ES45 →
O95479 0.979 O95479 →
Q9VQH2 0.974 Q9VQH2 →
MAP4K2 Mitogen-activated protein kinase kinase kinase kinase 2 0.973 landscape →
Q5NDF0 0.972 Q5NDF0 →
ABHD16A Phosphatidylserine lipase ABHD16A 0.971 landscape →
Q8C6B2 0.971 Q8C6B2 →
P09531 0.971 P09531 →
I3L5V6 0.971 I3L5V6 →
P59240 0.970 P59240 →
Q9ULE6 0.970 Q9ULE6 →
Q8R4K8 0.970 Q8R4K8 →
ATP6AP1 V-type proton ATPase subunit S1 0.970 landscape →
Q8R2H5 0.969 Q8R2H5 →
Q502B3 0.969 Q502B3 →
Q1JPD2 0.969 Q1JPD2 →
Q400G9 0.969 Q400G9 →
Q8MIU0 0.969 Q8MIU0 →
Q5RJL6 0.969 Q5RJL6 →
O35385 0.969 O35385 →
Q8TE68 0.968 Q8TE68 →
Q2KIY5 0.968 Q2KIY5 →
Q5VV41 0.968 Q5VV41 →
Q8K099 0.968 Q8K099 →